Tonix Pharmaceuticals announces company is looking to accelerate phase 2 study of TNX-601 ER
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joined Steve Darling from Proactive to share important news about the company's drug development...
Stay updated with breaking news from Seth Lederman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Seth Lederman joined Steve Darling from Proactive to share important news about the company's drug development...
Let’s take a closer look at how to get started in a franchise, even if you are not independently wealthy.
Tonix Pharmaceuticals (NASDAQ:TNXP) CEO Dr. Seth Lederman joined Steve Darling from Proactive to announced that Tonix Pharmaceuticals has initiated a Phase...
Topline Results from Four CNS Clinical Trials Expected in the Third and Fourth Quarters of 2023Fibromyalgia Topline Results Expected in the Fourth...
CHATHAM - Tonix Pharmaceuticals Holding Corp. , a biopharmaceutical company, today announced data supporting the memory- and cognition-enhancing effects of two Tonix drug candidates, TNX-601 ER and...